Ximedica

In Vitro Diagnostics

Transforming novel biochemical processes into high-value diagnostic platforms

Background:

vivoDx System with Smarticles Technology Disposables
GeneWEAVE

Need:

A simple and elegant workflow to utilize GeneWEAVE’s transformative Smarticles technology on a platform for the prevention and treatment guidance of multidrug-resistant organisms (MDRO). ​

Solution:

The Ximedica and GeneWEAVE teams collaborated on concept development of a revolutionary, low-cost disposable for sample-Smarticle processing and high-sensitivity, automated chemiluminescence detection. Ximedica incorporated their proprietary line of automation components to create a fully automated, continuous (random) access instrument and integrated disposable handling.​

Result:

The collaboration’s success attracted interest from multiple investors and culminated in Roche Diagnostics acquiring GeneWEAVE in 2015 for $425M total consideration.​

Wherever you are in your process, Ximedica can help.

contact us

At Ximedica, our people define who we are.

More About Our People

William Kane

William Kane

Mechanical Engineering Manager

John Sbardelli

John Sbardelli

Documentation Control Manager

Ryan Griswold

Ryan Griswold

Director of Mechanical Engineering

Joseph Kralicky

Joseph Kralicky

Principal Software Engineer

Christina Bradford

Christina Bradford

Senior Buyer

Odie Maknoxa

Odie Maknoxa

Senior Manufacturing Engineer